# Inhibin B/FSH Ratio as a Predictor of Testicular Pathology in NOA

> **NCT07415928** · — · COMPLETED · sponsor: **Elazıg Fethi Sekin Sehir Hastanesi** · enrollment: 73 (actual)

## Conditions studied

- Azoospermia, Nonobstructive
- Non-obstructive Azoospermia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07415928
- **Lead sponsor:** Elazıg Fethi Sekin Sehir Hastanesi
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2026-01-10
- **Primary completion:** 2026-02-02
- **Final completion:** 2026-02-05
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07415928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07415928, "Inhibin B/FSH Ratio as a Predictor of Testicular Pathology in NOA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07415928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*